The global anal fistula treatment market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The market growth is majorly attributed owing to the rising cases of inflammatory bowel diseases including ulcerative colitis and Crohn’s disease, increasing prevalence of anal fistula cases, launch of new drugs, and the increasing demand for non-surgical methods such as fibrin glue injection and adipose-derived stem cell therapy. There has been an increasing prevalence of anal fistula cases as it remains an ambiguous condition for the colorectal surgeon. 

According to the Global Burden of Disease (GBD) 2017 Inflammatory Bowel Disease Collaborators, there were 6.8 million cases of inflammatory bowel disease reported globally. The age standardized prevalence rate increased from 79.5 per 100,000 population in 1990 to 84.3 per 100,000 population in 2017. Adding to this, there is a surge in the demand for a safe and effective treatment that has no probability of recurrence coupled with fewer side effects that are pushing the key industry players to introduce advanced drugs and devices.

Some key players operating in the market include Medtronic plc, Cook Medical, and Takeda Pharmaceutical Co., Ltd. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on. For instance, in February 2018, AMI has launched FiXcision instrument, which consists of the guide, circular blade, probe and base plate for the precise treatment of anal fistulas.

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Treatment Type

o By Application

o By End-User 

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape: Medtronic plc, Cook Medical, and Takeda Pharmaceutical Co., Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Anal Fistula Treatment Market Report by Segment

By Type

• Surgical

• Non-Surgical

By Application

• Intersphincteric Fistula

• Transsphincteric Fistula

• Suprasphincteric Fistula

• Others

By End-User

• Hospitals

• Ambulatory Surgical Centers

• Others

Global Anal Fistula Treatment Market by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa